APA (7th ed.) Citation

D, S., XY, R., D, B., JZ, L., VP, W., A, A., . . . WA, H. (2025). The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism. Diabetes, 74(9), 1512. https://doi.org/10.2337/db24-0861

Chicago Style (17th ed.) Citation

D, Shantaram, et al. "The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism." Diabetes 74, no. 9 (2025): 1512. https://doi.org/10.2337/db24-0861.

MLA (9th ed.) Citation

D, Shantaram, et al. "The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism." Diabetes, vol. 74, no. 9, 2025, p. 1512, https://doi.org/10.2337/db24-0861.